Anti-Survivin (BIRC5, API4, EPR-1, baculoviral IAP repeat-containing 5 (survivin), survivin, apoptos

Alternate Name: BIRC5, API4, EPR-1, baculoviral IAP repeat-containing 5 (survivin), survivin, apoptosis inhibitor 4, Domain Information: , Gene Ontology Terms: 3-oxo-5-alpha-steroid 4-dehydrogenase activity, DNA repair, androgen metabolism, cell-cell signaling, electron transporter activity, integral to membrane, male gonad development, methylated-DNA-[protein]-cysteine S-methyltransferase activity, microsome, oxidoreductase activity, sex determination, sex differentiation, Application(s): Peptide ELISA: antibody detection limit dilution 1:16,000. Western Blot: Approx 18kD band observed in Human T cell line MOLT4 lysates (calculated MW of 16.4kD according to NP_001159.2 and 18.6kD according to NP_001012271.1). Recommended concentration: 0.01-0.5ug/ml. 0.01ug/ml staining of Molt-4 lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence. Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot and store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer. Peptide Blocking: Corresponding peptide is available for Peptide Blocking studies. See S8500-06N-P. Antibody is typically 0.5mg/ml and peptide is supplied as a 100ul pellet. When peptide is reconstituted in 200ul water, the concentration would also be 0.5mg/ml. To start, the best ratio would be 1:1 (molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. It is best is to have two identical blots to be incubated with equal amount of antibody, but one with the antibody pre-adsorbed to the peptide for 20min. Then incubate and develop the two blots in parallel.